Empagliflozin in Heart Failure with a Preserved Ejection Fraction

SD Anker, J Butler, G Filippatos… - … England Journal of …, 2021 - hal-emse.ccsd.cnrs.fr
Background: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for
heart failure in patients with heart failure and a reduced ejection fraction, but their effects in …

Empagliflozin in heart failure with a preserved ejection fraction

EMPEROR-Preserved Trial … - New England …, 2021 - utsouthwestern.elsevierpure.com
BACKGROUND Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization
for heart failure in patients with heart failure and a reduced ejection fraction, but their effects …

Empagliflozin in heart failure with a preserved ejection fraction

S Anker, J Butler, G Filippatos, J Ferreira… - NEW ENGLAND …, 2021 - boa.unimib.it
BACKGROUND Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization
for heart failure in patients with heart failure and a reduced ejection fraction, but their effects …

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

SD Anker, J Butler, G Filippatos… - … England Journal of …, 2021 - hal.univ-lorraine.fr
Background: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for
heart failure in patients with heart failure and a reduced ejection fraction, but their effects in …

Empagliflozin in heart failure with a preserved ejection fraction

SD Anker, J Butler, G Filippatos… - … England Journal of …, 2021 - snucm.elsevierpure.com
BACKGROUND Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization
for heart failure in patients with heart failure and a reduced ejection fraction, but their effects …

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for
heart failure in patients with heart failure and a reduced ejection fraction, but their effects in …

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

SD Anker, J Butler, F Gerasimos, JP Ferreira, E Bocchi… - 2021 - repositorio.fleni.org.ar
Background: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for
heart failure in patients with heart failure and a reduced ejection fraction, but their effects in …

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi… - 2021 - figshare.le.ac.uk
BACKGROUND Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization
for heart failure in patients with heart failure and a reduced ejection fraction, but their effects …

Empagliflozin in heart failure with a preserved ejection fraction

EMPEROR-Preserved Trial … - New England Journal …, 2021 - yonsei.elsevierpure.com
BACKGROUND Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization
for heart failure in patients with heart failure and a reduced ejection fraction, but their effects …

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

SD Anker, J Butler, G Filippatos, JP Ferreira… - New England Journal …, 2021 - cir.nii.ac.jp
Empagliflozin in Heart Failure with a Preserved Ejection Fraction | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …